• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[抗糖尿病治疗对2型糖尿病患者心血管疾病及其并发症风险的影响]

[Impact of antidiabetic therapy on the risk of cardiovascular diseases and their complications in patients with type 2 diabetes mellitus].

作者信息

Ametov A S, P'ianykh O P, Chernikova N A

出版信息

Ter Arkh. 2010;82(8):71-5.

PMID:20873250
Abstract

In Russia, diabetes mellitus afflicts 8 million people, 90% of them had type 2 diabetes mellitus (T2DM) and this figure is growing steadily. At the same time there is a rise in the incidence of macrovascular events (unstable angina pectoris, myocardial infarction). Coronary heart disease and its attack are a major cause of death in the developed countries, including Russia. To prevent chronic complications of DM is likely to be the most urgent task of not only modern diabetology, but also medical science as a whole. In this connection, of great value are the results of a few large international randomized controlled studies, the main objective of which was to evaluate the impact of the rate of blood glucose control on the incidence and outcomes of cardiovascular diseases in patients with T2DM

摘要

在俄罗斯,糖尿病折磨着800万人,其中90%患有2型糖尿病(T2DM),且这一数字在稳步增长。与此同时,大血管事件(不稳定型心绞痛、心肌梗死)的发病率也在上升。冠心病及其发作是包括俄罗斯在内的发达国家的主要死因。预防糖尿病的慢性并发症可能不仅是现代糖尿病学,也是整个医学领域最紧迫的任务。就此而言,一些大型国际随机对照研究的结果具有重要价值,其主要目的是评估血糖控制率对T2DM患者心血管疾病发病率和结局的影响。

相似文献

1
[Impact of antidiabetic therapy on the risk of cardiovascular diseases and their complications in patients with type 2 diabetes mellitus].[抗糖尿病治疗对2型糖尿病患者心血管疾病及其并发症风险的影响]
Ter Arkh. 2010;82(8):71-5.
2
Early and intensive therapy for management of hyperglycemia and cardiovascular risk factors in patients with type 2 diabetes.2 型糖尿病患者的高血糖和心血管危险因素的早期强化治疗。
Clin Ther. 2011 Jun;33(6):665-78. doi: 10.1016/j.clinthera.2011.04.025.
3
Opinion: Tight blood glucose control and cardiovascular disease in the elderly diabetic? Let the randomized controlled trials speak for themselves.观点:老年糖尿病患者的严格血糖控制与心血管疾病?让随机对照试验来说话。
Geriatrics. 2008 Aug;63(8):8-10.
4
Glycemic targets for patients with type 2 diabetes mellitus.2型糖尿病患者的血糖目标
Mt Sinai J Med. 2009 Jun;76(3):227-33. doi: 10.1002/msj.20117.
5
Effects of intensive glucose control on incidence of cardiovascular events in patients with type 2 diabetes: a meta-analysis.强化血糖控制对 2 型糖尿病患者心血管事件发生率的影响:一项荟萃分析。
Ann Med. 2010 May 6;42(4):305-15. doi: 10.3109/07853891003796752.
6
[Acarbose--an effective drug for the prevention of type 2 diabetes and cardiovascular diseases?].阿卡波糖——一种预防2型糖尿病和心血管疾病的有效药物?
Duodecim. 2003;119(20):1921-3.
7
Does intensive glycemic control improve cardiovascular outcomes?强化血糖控制能否改善心血管结局?
Nat Clin Pract Endocrinol Metab. 2008 Oct;4(10):529. doi: 10.1038/ncpendmet0953.
8
Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people.需要降糖治疗的糖尿病患者与既往有心肌梗死的非糖尿病患者具有相同的心血管风险:一项对330万人的人群研究。
Circulation. 2008 Apr 15;117(15):1945-54. doi: 10.1161/CIRCULATIONAHA.107.720847. Epub 2008 Mar 31.
9
Therapeutic potential of aleglitazar, a new dual PPAR-α/γ agonist: implications for cardiovascular disease in patients with diabetes mellitus.阿格列扎治疗潜能,新型双重 PPAR-α/γ 激动剂:对糖尿病心血管疾病患者的影响。
Am J Cardiovasc Drugs. 2010;10(4):209-16. doi: 10.2165/11539500-000000000-00000.
10
Cardiovascular risk and cardiometabolic protection: role of glitazones.心血管风险与心脏代谢保护:格列酮类药物的作用
J Nephrol. 2008 Nov-Dec;21(6):826-35.